A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...
“While GLP-1-based therapies have revolutionized patient care for obesity ... harmful triglycerides and cholesterol while ...
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...
Lixisenatide: A type of glucagon-like peptide-1 (GLP-1) receptor agonist to help lower blood sugar in people with type 2 ...
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...
The company’s lead product is a long-acting GLP-1 drug known as MET-097i. In a Phase 1 trial, five weekly injections of the ...
Hosted on MSN1d
Why's It So Hard to Get a GLP-1 Prescription?However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback